Objective:To observe the efficacy and toxicity of domestic epirubicin in treatment of non Hodgkin's lymphoma, breast cancer, and non small cell lung cancer.
Methods: 9 patients with pathologically confirmed high risk breast cancer, lymphoma, and small cell lung cancer, previously treated with chemotherapy were treated with this procedure.